(Q27852820)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24496303%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

Alessandro Pancrazzi

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24496303%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

Rhett P. Ketterling

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24496303%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

author name string

T L Lasho

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24496303%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

G Rotunno

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24496303%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

C Finke

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24496303%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

C Mannarelli

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24496303%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

A A Belachew

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24496303%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

E A Wassie

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24496303%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

C A Hanson

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24496303%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

A Pardanani

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24496303%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

A M Vannucchi

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24496303%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

A Tefferi

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24496303%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

language of work or name

1 reference

July 2014

0 references

published in

Leukemia

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24496303%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

volume

28

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24496303%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

page(s)

1494-1500

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24496303%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24496303%20AND%20SRC:MED&resulttype=core&format=json

Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported

4 June 2020

copyright license

start time

5 February 2014

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Somatic mutations of calreticulin in myeloproliferative neoplasms

1 reference

12 December 2020

Clinical effect of point mutations in myelodysplastic syndromes

1 reference

12 December 2020

A dynamic prognostic model to predict survival in primary myelofibrosis: a study by the IWG-MRT (International Working Group for Myeloproliferative Neoplasms Research and Treatment).

1 reference

12 December 2020

Mayo prognostic model for WHO-defined chronic myelomonocytic leukemia: ASXL1 and spliceosome component mutations and outcomes

1 reference

12 December 2020

Predictors of greater than 80% 2-year mortality in primary myelofibrosis: a Mayo Clinic study of 884 karyotypically annotated patients.

1 reference

12 December 2020

Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2

1 reference

12 December 2020

New prognostic scoring system for primary myelofibrosis based on a study of the International Working Group for Myelofibrosis Research and Treatment

1 reference

12 December 2020

Mutations and prognosis in primary myelofibrosis

1 reference

12 December 2020

The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes

1 reference

12 December 2020

JAK2 or CALR mutation status defines subtypes of essential thrombocythemia with substantially different clinical course and outcomes.

1 reference

12 December 2020

Impact of calreticulin mutations on clinical and hematological phenotype and outcome in essential thrombocythemia

1 reference

12 December 2020

U2AF1 mutations in primary myelofibrosis are strongly associated with anemia and thrombocytopenia despite clustering with JAK2V617F and normal karyotype.

1 reference

12 December 2020

SRSF2 mutations in primary myelofibrosis: significant clustering with IDH mutations and independent association with inferior overall and leukemia-free survival

1 reference

12 December 2020

Calreticulin for better or for worse, in sickness and in health, until death do us part.

1 reference

12 December 2020

IDH mutations in primary myelofibrosis predict leukemic transformation and shortened survival: clinical evidence for leukemogenic collaboration with JAK2V617F

1 reference

12 December 2020

Myelodysplastic syndromes are induced by histone methylation–altering ASXL1 mutations

1 reference

12 December 2020

An overview on CALR and CSF3R mutations and a proposal for revision of WHO diagnostic criteria for myeloproliferative neoplasms

1 reference

12 December 2020

Refined cytogenetic-risk categorization for overall and leukemia-free survival in primary myelofibrosis: a single center study of 433 patients

1 reference

12 December 2020

DIPSS plus: a refined Dynamic International Prognostic Scoring System for primary myelofibrosis that incorporates prognostic information from karyotype, platelet count, and transfusion status

1 reference

12 December 2020

CALR vs JAK2 vs MPL-mutated or triple-negative myelofibrosis: clinical, cytogenetic and molecular comparisons

1 reference

12 December 2020

Integration of cytogenetic and molecular alterations in risk stratification of 318 patients with de novo non-M3 acute myeloid leukemia.

1 reference

12 December 2020

Deletion of Asxl1 results in myelodysplasia and severe developmental defects in vivo

1 reference

12 December 2020

JAK inhibitor therapy for myelofibrosis: critical assessment of value and limitations

1 reference

12 December 2020

Spliceosome mutations involving SRSF2, SF3B1, and U2AF35 in chronic myelomonocytic leukemia: prevalence, clinical correlates, and prognostic relevance.

1 reference

12 December 2020

Identifiers

DOI

10.1038/LEU.2014.57

2 references

Consolidated OpenCitations Corpus – April 2017

2278095

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24496303%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

4 June 2020

1034707344

0 references

2278095

1 reference

Consolidated OpenCitations Corpus – April 2017

Consolidated OpenCitations Corpus – April 2017

2 references

2278095

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24496303%20AND%20SRC:MED&resulttype=core&format=json